Institute of Oncology Ljubljana
90
22
31
42
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 45/100
0.0%
0 terminated/withdrawn out of 90 trials
100.0%
+13.5% vs industry average
0%
0 trials in Phase 3/4
10%
4 of 42 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (90)
Prophylactic Radiotherapy to Prevent Bone Complications in Patients With Metastatic Solid Cancers
Role: lead
Electrochemotherapy of Posterior Resection Surface for Lowering Disease Recurrence Rate in Pancreatic Cancer (PanECT Study)
Role: collaborator
Image-Guided Central Catheter Insertion With Concurrent Assessment of Vascular Wall Integrity
Role: collaborator
Late Endocrine and Metabolic Consequences After Childhood Brain Tumor Treatment
Role: lead
Effect of Perioperative Lidocaine or High-Dose Dexamethasone on Immune Response in Colon Cancer Surgery (PILDI Study)
Role: lead
Adherence to Aromatase Inhibitors ± Abemaciclib Treatment in Patients With Early-stage HER2-negative Breast Cancer
Role: lead
Clinical and Functional Retinal Changes Associated With BRAF/MEK Inhibitor Therapy in Patients With Malignant Melanoma
Role: lead
Liquid Biopsy Genotyping Using Oncomine Precision Assay GX in Advanced NSCLC
Role: lead
Sense of Coherence and Quality of Life in Prostate Cancer Patients Treated With Radical Radiotherapy
Role: lead
Predictive Factors for CNS Metastases in Early Breast Cancer Using Liquid Biopsy (AKRA CŽS)
Role: lead
Pilot Study of Radiation-Induced Xerostomia Treatment With Allogeneic Mesenchymal Stromal Stem Cells
Role: lead
Cognitive Impairment in Patients With Diffuse Large B-Cell Lymphoma
Role: lead
Electrochemotherapy for Recurrent Vulvar Cancer
Role: lead
IFN-Gamma Expression as a Predictor of Response to Immune Checkpoint Inhibitors in First-Line Metastatic Melanoma
Role: lead
Circulating and Urinary Exosomal miRNA as Predictors of Treatment Response in Advanced Kidney Cancer
Role: lead
ASTRA Study: Circulating Tumor Cells in Blood of Patients With High-Grade Serous Ovarian Cancer
Role: lead
Gastrointestinal Microbiome and Response to Immunotherapy in Metastatic Malignant Melanoma
Role: lead
BRCA1, RASSF1A and PTEN Methylation in Breast Lesions of Uncertain Malignant Potential
Role: lead
Retinal Structural and Functional Changes in Patients Treated With BRAF/MEK Inhibitors
Role: lead
Gene Methylation for Diagnosis of Breast Lesions
Role: lead